Yonhap Infomax NewsDec 30
South Korea’s Fair Trade Commission is considering designating Coupang as a market-dominant operator after its market share surged, with antitrust reviews and hearings underway regarding alleged unfair practices.
#YonhapInfomax #Coupang #FairTradeCommission #MarketDominance #AntitrustReview #41TrillionWon #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97689
Joo Byung-ki, Chair of Fair Trade Commission, Says Coupang May Be Designated as Market-Dominant Operator (Comprehensive 2nd Report)

South Korea’s Fair Trade Commission is considering designating Coupang as a market-dominant operator after its market share surged, with antitrust reviews and hearings underway regarding alleged unfair practices.

Yonhap Infomax
Yonhap Infomax NewsDec 8
Paramount Skydance has launched a $54 billion hostile takeover bid for Warner Bros. Discovery, countering Netflix’s $72 billion deal and intensifying the battle for media dominance as antitrust scrutiny looms.
#YonhapInfomax #ParamountSkydance #WarnerBrosDiscovery #HostileTakeover #Netflix #AntitrustReview #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94479
'I Had My Eye on That'—Paramount Launches Hostile Takeover Bid for Warner Bros.

Paramount Skydance has launched a $54 billion hostile takeover bid for Warner Bros. Discovery, countering Netflix’s $72 billion deal and intensifying the battle for media dominance as antitrust scrutiny looms.

Yonhap Infomax
Yonhap Infomax NewsNov 10
Celltrion has completed all regulatory reviews for its acquisition of Eli Lilly’s US manufacturing facility, paving the way for expanded biopharmaceutical production and CMO business growth.
#YonhapInfomax #Celltrion #EliLilly #AntitrustReview #ManufacturingFacility #700BillionWonInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90145
Celltrion Completes Final Antitrust Review for Acquisition of Eli Lilly’s US Manufacturing Facility

Celltrion has completed all regulatory reviews for its acquisition of Eli Lilly’s US manufacturing facility, paving the way for expanded biopharmaceutical production and CMO business growth.

Yonhap Infomax